Categories
Change Password!
Reset Password!
Magnetic sphincter augmentation (MSA) can be
useful for recovery from regurgitation and
discontinue the use of proton pump inhibitors (PPI) in gastroesophageal reflux
disease (GERD).
MSA and transoral incisionless fundoplication (TIF) were found to have a similar improvement in GERD-Health Related Quality of Life (GERD-HRQL) score, but MSA had better outcomes as compared to TIF2 in terms of patient satisfaction, after procedure regurgitation and the number of patients who stopped using PPI, concluded a study in Endoscopy international open.
Saurabh Chandan et al. compared the efficacy of both procedures- MSA and TIF2 as evaluated via GERD-HRQL) score, patient satisfaction, improved after procedure regurgitation, and the number of patients who stopped using PPI therapy at follow-up.
After a widespread database
search to recognize suitable studies, 24 studies with 1942 patients were
included. Of particular interest, a significantly greater number of patients
with MSA (91.1 %) described recovery in regurgitation compared to patients who
opted for the TIF2 procedure (73.1 %). Furthermore, 91.3 % of patients with MSA
were able to completely discontinue PPI therapy than only 63.8 % in TIF2. The
body mass index and occurrence of a hiatal hernia in patients did not affect
the procedural outcomes.
Endoscopy International Open
Clinical efficacy and safety of magnetic sphincter augmentation (MSA) and transoral incisionless fundoplication (TIF2) in refractory gastroesophageal reflux disease (GERD): a systematic review and meta-analysis
Saurabh Chandan et al.
Comments (0)